Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.
Huang X, Schwind S, Santhanam R, Eisfeld AK, Chiang CL, Lankenau M, Yu B, Hoellerbauer P, Jin Y, Tarighat SS, Khalife J, Walker A, Perrotti D, Bloomfield CD, Wang H, Lee RJ, Lee LJ, Marcucci G.
Huang X, et al.
Oncotarget. 2016 Sep 13;7(37):59273-59286. doi: 10.18632/oncotarget.11150.
Oncotarget. 2016.
PMID: 27517749
Free PMC article.